mifepristone has been researched along with Abnormalities, Congenital in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aliberti, C; Bastianelli, C; Farris, M; Parachini, M | 1 |
Brownell, P; Dickinson, JE; McGinnis, K; Nathan, EA | 1 |
Amar, E; Barjhoux, CE; Bernard, N; Bos-Thompson, MA; Carlier, P; Descotes, J; Elefant, E; Tebacher, M; Vial, T | 1 |
Ellertson, C; Norris Turner, A | 1 |
Jansen, RP | 1 |
1 review(s) available for mifepristone and Abnormalities, Congenital
Article | Year |
---|---|
Unfinished feticide.
Topics: Abortion, Eugenic; Abortion, Induced; Abortion, Legal; Congenital Abnormalities; Ethics, Medical; Female; Fetal Death; France; Humans; Internationality; Liability, Legal; Malpractice; Mifepristone; Pregnancy; Pregnancy, Multiple | 1990 |
4 other study(ies) available for mifepristone and Abnormalities, Congenital
Article | Year |
---|---|
Second-trimester induced abortions in two tertiary centres in Rome.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Alprostadil; Congenital Abnormalities; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Rome; Socioeconomic Factors | 2014 |
Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Congenital Abnormalities; Critical Pathways; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Length of Stay; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Western Australia | 2010 |
Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Congenital Abnormalities; Female; Follow-Up Studies; France; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies | 2013 |
How safe is emergency contraception?
Topics: Congenital Abnormalities; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Administration Schedule; Drug Interactions; Estrogens; Female; Fertility; Humans; Intrauterine Devices, Copper; Mifepristone; Pregnancy; Progestins; Public Health; Risk Assessment; Sexually Transmitted Diseases; United States; United States Food and Drug Administration; World Health Organization | 2002 |